A clinical trial for patients.

Trial ID: NCT06449209

Safety, Preliminary Effectiveness of BNT327, an Investigational Therapy for Patients With Small-cell Lung Cancer in Combination With Chemotherapy

Prescreen Now

Trial Details

Estimated Enrollment

110 Participants

Phase

3

Eligibility Criteria

Participants must:

Participants must not:

Commitments from you

Travel

You will need to travel to one of the 31 sites taking part in this clinical trial. Sites are located in:

Actively Recruiting

Knoxville, Tennessee, United States
Lincoln, Nebraska, United States
White Plains, New York, United States
Frederick, Maryland, United States
Cedar Rapids, Iowa, United States
Ames, Iowa, United States
Southaven, Mississippi, United States
Houston, Texas, United States
Kettering, Ohio, United States
North Worcester, Massachusetts, United States
Richmond, Virginia, United States
St. Louis, Missouri, United States
Cincinnati, Ohio, United States
Sugar Land, Texas, United States
Fort Wayne, Indiana, United States
Elizabethtown, Kentucky, United States
New York, New York, United States
Fredericksburg, Virginia, United States

Not yet Recruiting

(Awaiting confirmation) Baton Rouge, Louisiana, United States
(Awaiting confirmation) Burlington, Massachusetts, United States
(Awaiting confirmation) Fountain Hill, Pennsylvania, United States
(Awaiting confirmation) Cleveland, Ohio, United States
(Awaiting confirmation) Tucson, Arizona, United States
(Awaiting confirmation) Winchester, Virginia, United States
(Awaiting confirmation) San Antonio, Texas, United States

Potential Benefits

Treatment in trials is investigational as effectiveness and safety have not been established. There is no guarantee that they will become commercially available.

Potential alleviation of symptoms
Regular health check ups
Help others by contributing to medical knowledge

Frequently Asked Questions (FAQs)

How can I check to see if I am eligible for this trial?

You can check if you are potentially eligible for this trial by completing a set of screening questions. You can find these on this web page by finding the ‘Get Started’ button.

What does a typical research study look like?

Clinical trials help determine the safety and effectiveness of new treatments. A research plan or protocol is created that outlines how trial participants may receive interventions which can include investigational medications, devices, or procedures. The trial may compare a new medical approach to a standard treatment option already available, to a placebo with no active investigational medication, or to no intervention at all. The trial team will share more details before you participate.

Can I stop the trial at anytime?

You can leave the study at any time by telling your study doctor that you no longer want to take part. Your choice will not change the quality of care you receive outside of this study.

What personal information is collected about you for the study?

The study doctor and other study staff will collect your personal information. This may include:

Your name, address, telephone number, health insurance number where applicable.
Your age, gender, ethnic and racial background.
Lifestyle information; health and medical history.
Your study treatments and response to study treatments.
Data resulting from testing your biological samples and any images taken.

Who has access to your personal information?

All your personal information collected for this study will be stored in the study medical records at the study site. Sponsor staff, review boards and ethics committees (that approve and monitor studies), and others may check the study records. This is done to make sure that the study is being run properly. Regulatory agencies, such as the US Food and Drug Administration (FDA), European Medicine Agency (EMA) or others, review and approve new medicines. These agencies will be granted direct access to your information. This is so they can verify clinical trial procedures and/or data. If you share your personal data to contact a site, that data will be used by Citeline to contact you about clinical trials and related information.